AU2002368447A1 - Broad-spectrum lps based vaccines of unencapsulated strains ofhaemophilus influenzae and other pathogenic species of gram-negative bacteria - Google Patents

Broad-spectrum lps based vaccines of unencapsulated strains ofhaemophilus influenzae and other pathogenic species of gram-negative bacteria

Info

Publication number
AU2002368447A1
AU2002368447A1 AU2002368447A AU2002368447A AU2002368447A1 AU 2002368447 A1 AU2002368447 A1 AU 2002368447A1 AU 2002368447 A AU2002368447 A AU 2002368447A AU 2002368447 A AU2002368447 A AU 2002368447A AU 2002368447 A1 AU2002368447 A1 AU 2002368447A1
Authority
AU
Australia
Prior art keywords
gram
broad
spectrum
negative bacteria
based vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002368447A
Inventor
Massimo Porro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biosynth SRL
Original Assignee
Biosynth SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosynth SRL filed Critical Biosynth SRL
Publication of AU2002368447A1 publication Critical patent/AU2002368447A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AU2002368447A 2002-12-06 2002-12-06 Broad-spectrum lps based vaccines of unencapsulated strains ofhaemophilus influenzae and other pathogenic species of gram-negative bacteria Abandoned AU2002368447A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT2002/000768 WO2004052394A1 (en) 2002-12-06 2002-12-06 Broad-spectrum lps based vaccines of unencapsulated strains of haemophilus influenzae and other pathogenic species of gram-negative bacteria

Publications (1)

Publication Number Publication Date
AU2002368447A1 true AU2002368447A1 (en) 2004-06-30

Family

ID=32500471

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002368447A Abandoned AU2002368447A1 (en) 2002-12-06 2002-12-06 Broad-spectrum lps based vaccines of unencapsulated strains ofhaemophilus influenzae and other pathogenic species of gram-negative bacteria

Country Status (2)

Country Link
AU (1) AU2002368447A1 (en)
WO (1) WO2004052394A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9107906B1 (en) 2014-10-28 2015-08-18 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ561374A (en) * 2005-04-11 2009-02-28 Sanofi Pasteur Polymyxin B analogs for LPS detoxification
EP1712559A1 (en) * 2005-04-11 2006-10-18 Sanofi Pasteur Polymyxin B analogs for LPS detoxification
US7507718B2 (en) 2005-04-11 2009-03-24 Sanofi Pasteur Polymyxin B analogs for LPS detoxification
MX362955B (en) 2012-03-22 2019-02-26 The Chemo Sero Therapeutic Res Institute Lps vaccine.
US10500263B2 (en) * 2014-07-25 2019-12-10 Biosynth S.R.L. Glycoconjugate vaccines comprising basic units of a molecular construct expressing built-in multiple epitopes for the formulation of a broad-spectrum vaccine against infections due to enteropathogenic bacteria

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5371186A (en) * 1991-02-11 1994-12-06 Biosynth S.R.L. Synthetic peptides for detoxification of bacterial endotoxins and for the prevention and treatment of septic shock

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9107906B1 (en) 2014-10-28 2015-08-18 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US9714283B2 (en) 2014-10-28 2017-07-25 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US9815886B2 (en) 2014-10-28 2017-11-14 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US9969793B2 (en) 2014-10-28 2018-05-15 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US10683343B2 (en) 2014-10-28 2020-06-16 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US11339206B2 (en) 2014-10-28 2022-05-24 Adma Biomanufacturing, Llc Compositions and methods for the treatment of immunodeficiency
US11780906B2 (en) 2014-10-28 2023-10-10 Adma Biomanufacturing, Llc Compositions and methods for the treatment of immunodeficiency
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
US11084870B2 (en) 2017-03-15 2021-08-10 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
US11897943B2 (en) 2017-03-15 2024-02-13 Adma Biomanufacturing, Llc Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection

Also Published As

Publication number Publication date
WO2004052394A1 (en) 2004-06-24

Similar Documents

Publication Publication Date Title
EP1357938B8 (en) Hyperblebbing bacterial strains and use thereof for production of vaccines
AU2003303894A1 (en) Inactivated probiotic bacteria and methods of use thereof
AU2002305941A1 (en) Quantitative assay for the simultaneous detection and speciation of bacterial infections
IL173692A0 (en) Bacterial strains, compositions including same and probiotic use thereof
AU2003208933A1 (en) Methods and apparatus for assays of bacterial spores
HUP0303892A3 (en) Bacterial host strains
AU2002325197A1 (en) Bacterial strains belonging to lactobacillus species and their use in food and feed industry
AU2001244109A1 (en) Closure of bacterial ghosts
AU6373501A (en) Preparation that contains the intestinal beneficial bacterium fermentation culture
AU2002344447A1 (en) Bacterium of the genus bifidobacterium and fermented foods using the same
AU2000255628A1 (en) Formulation comprising thymol useful in the treatment of drug resistant bacterial infections
AU2002368447A1 (en) Broad-spectrum lps based vaccines of unencapsulated strains ofhaemophilus influenzae and other pathogenic species of gram-negative bacteria
AU2003225946A1 (en) Methods and compositions for vaccination against or involvingenterobacteriaceae bacteria
AU2003267936A1 (en) Methods and devices for the detection of pathogenic microorganisms and their antimicrobial susceptilbility
AU2002346642A1 (en) Probiotic formulation and method for reduction of pathogenic bacteria
AU2002210536A1 (en) Detection of pathogenic bacteria
AU4791799A (en) Screening of neisserial vaccine candidates and vaccines against pathogenic neisseria
AU2003289930A1 (en) Method for the detection of pathogenic gram positive bacteria from the genera staphylococcus, enterococcus and streptococcus
AU2002361548A1 (en) Compositions and methods for bacteria detection
AU2001267162A1 (en) Method for the preparation of yoghurt and other fermented milk products
AU2003261782A1 (en) Bacteriophages and remedies for bacterial infection
AU2002353774A1 (en) Products and methods for treating microbial infections
AU2002359014A1 (en) Method for making fermented food and fermented food made thereby having suppressive effect against helicobactor-pylori and food-poisoning bacillus
AU2002326303A1 (en) Methods for attenuation of virulence in bacteria
AU2003299872A1 (en) Vmp-like sequences of pathogenic borrelia species and strains

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase